| |
|
|
 |
|
print
|
|
|
|
|
More than 25 years ago, Lonza established the concept of custom manufacturing, recognizing the trend towards outsourcing, mainly in the pharmaceutical industry.
Since the early 1980s, Lonza has worked with the largest international pharmaceutical and biotechnology companies world-wide and has significantly influenced the outsourcing market in offering exclusive manufacturing services for the production of fine chemicals, intermediates, active pharmaceutical ingredients, peptides, oligonucleotides, recombinant therapeutic proteins, and monoclonal antibodies (mAbs).
These molecules are manufactured based on Lonza Custom Manufacturing’s core technologies of advanced chemical synthesis, peptide synthesis, microbial fermentation, mammalian cell culture, and cell therapy (regenerative medicine).
|
|
|
|
|
|
|
|
|
 |
